FDA
approval
· 2023-02-22
FDA Approved: LAMPIT — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
Summary
FDA supplemental application for Lampit (nifurtimox) from Bayer HealthCare Pharmaceuticals Inc., seeking regulatory action on an updated indication/label for th…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LAMPIT (NIFURTIMOX)